Pancreatic Cancer Research

ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years

Yi Zhang

Matched on ORCID iD 0000-0003-3641-0629; OpenAlex author ID A5100388327. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Radiotherapy combined with serplulimab, and chemotherapy as first-line treatment for metastatic pancreatic adenocarcinoma: a multicenter, single-arm, phase II … Co-author DOI 10.1158/1078-0432.ccr-26-1824↗
  2. Umbilical neoplasm as the first sign of pancreatic adenocarcinoma. Last author DOI 10.15537/1658-3175.6021↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zixing Huang · 1 shared paper, 2026 · strength 0.19
  2. Chen Chang · 1 shared paper, 2026 · strength 0.19
  3. Junjie Xiong · 1 shared paper, 2026 · strength 0.19
  4. Yi Cheng · 1 shared paper, 2026 · strength 0.19
  5. Ke Cheng · 1 shared paper, 2026 · strength 0.19
  6. Dan Cao · 1 shared paper, 2026 · strength 0.19
  7. Xiaorui Zhu · 1 shared paper, 2026 · strength 0.19
  8. Qingqing Leng · 1 shared paper, 2026 · strength 0.19
  9. Wanting Hou · 1 shared paper, 2026 · strength 0.19
  10. Chenyan Zhang · 1 shared paper, 2026 · strength 0.19
  11. Bole Tian · 1 shared paper, 2026 · strength 0.19
  12. Bole Tian · 1 shared paper, 2014 · strength 0.06
  13. Anping Su · 1 shared paper, 2014 · strength 0.06
  14. Min Yang · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.